InMed Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.

About INM

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. 

CEO
Eric A. Adams
CEOEric A. Adams
Employees
13
Employees13
Headquarters
Vancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded
1981
Founded1981
Employees
13
Employees13

INM Key Statistics

Market cap
3.55M
Market cap3.55M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
—
Dividend yield—
Average volume
376.80K
Average volume376.80K
High today
$3.50
High today$3.50
Low today
$2.84
Low today$2.84
Open price
$3.40
Open price$3.40
Volume
324.35K
Volume324.35K
52 Week high
$15.70
52 Week high$15.70
52 Week low
$1.72
52 Week low$1.72

People also own

Based on the portfolios of people who own INM. This list is generated using Robinhood data, and it’s not a recommendation.
Mullen Automotive
SNDL
Tilray Brands
FuelCell Energy
Tonix Pharmaceuticals
NIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.